Delix Therapeutics
Boston
About Delix Therapeutics
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens’novel neuroplasticity-promoting therapeutics’to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $144.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: delixtherapeutics.com
Industries & Categories
Biotechnology, Health Care, Life Science, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/delix-therapeutics-57161 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.